Therapy for relapsed multiple myeloma

Mohammed A. Aljama, M. Hasib Sidiqi, David Dingli

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Despite significant progress in our understanding and the development of novel therapies, most patients with multiple myeloma will experience relapse of their disease. Therapy of relapsed myeloma has improved due to the availability of novel agents that are highly active against the disease. However, the selection of therapy can be challenging due to the emergence of toxicities, comorbidities and frailty. In the following we discuss our approach to the treatment of the patient with relapsed myeloma.

Original languageEnglish (US)
Pages (from-to)174-184
Number of pages11
JournalPanminerva Medica
Issue number4
StatePublished - Dec 2018


  • Multiple myeloma
  • Recurrence
  • Therapeutics

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Therapy for relapsed multiple myeloma'. Together they form a unique fingerprint.

Cite this